Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1994
Actin filaments and the spatial positioning of mRNAS
G J Bassell, K L Taneja, E H Kislauskis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2016
Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort
Duygu Tosun, Yun-Fei Chen, Peng Yu, et al.
Lakartidningen
|
September 23, 1981
[Reference values of lead in blood and urine in adults]
K Anderson, K Andersson, M Botvalde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels
J N Wilcox, R R Subramanian, C L Sundell, et al.
FEBS Letters
|
August 3, 1992
Molecular cloning and characterization of human endothelial nitric oxide synthase
P A Marsden, K T Schappert, H S Chen, et al.
The Journal of Biological Chemistry
|
December 22, 2000
Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns
R H Triepels, B J Hanson, L P van den Heuvel, et al.
Circulation
|
September 14, 1999
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
P E Tummala, X L Chen, C L Sundell, et al.
The American Journal of Psychiatry
|
August 18, 1999
Changes in weight during a 1-year trial of fluoxetine
D Michelson, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry
|
July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapy
J Zajecka, J D Amsterdam, F M Quitkin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Advances in Experimental Medicine and Biology
|
January 1, 1994
Actin filaments and the spatial positioning of mRNAS
G J Bassell, K L Taneja, E H Kislauskis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2016
Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort
Duygu Tosun, Yun-Fei Chen, Peng Yu, et al.
Lakartidningen
|
September 23, 1981
[Reference values of lead in blood and urine in adults]
K Anderson, K Andersson, M Botvalde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels
J N Wilcox, R R Subramanian, C L Sundell, et al.
FEBS Letters
|
August 3, 1992
Molecular cloning and characterization of human endothelial nitric oxide synthase
P A Marsden, K T Schappert, H S Chen, et al.
The Journal of Biological Chemistry
|
December 22, 2000
Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns
R H Triepels, B J Hanson, L P van den Heuvel, et al.
Circulation
|
September 14, 1999
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
P E Tummala, X L Chen, C L Sundell, et al.
The American Journal of Psychiatry
|
August 18, 1999
Changes in weight during a 1-year trial of fluoxetine
D Michelson, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry
|
July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapy
J Zajecka, J D Amsterdam, F M Quitkin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2015
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric R Siemers, Karen L Sundell, Christopher Carlson, et al.
Page
of 7